RNS Number:5740O
CeNeS Pharmaceuticals PLC
12 August 2003


                    CeNeS Pharmaceuticals Plc ("the Company")
                                        
                                        
                                Issue of Equity



Further to the announcement on 8 August 2003 the Company has issued a total of
19,815,259 ordinary shares of 1p each in connection with the conversion by Elan
Corporation plc of its outstanding convertible loan notes.


Application has been made for these shares to be admitted to trading on AIM and
it is expected that admission to trading on AIM will become effective tomorrow,
13 August 2003.








                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
LISFLLFFXVBLBBE